For the current REF see the REF 2021 website REF 2021 logo

Output details

1 - Clinical Medicine

University College London

Return to search Previous output Next output
Output 0 of 0 in the submission
Article title

Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: A phase 1 dose-escalation trial

Type
D - Journal article
Title of journal
The Lancet
Article number
-
Volume number
379
Issue number
9829
First page of article
1893
ISSN of journal
0140-6736
Year of publication
2012
URL
-
Number of additional authors
16
Additional information

The author made a substantial contribution to the conception and design of the study, and to the analysis and interpretation of study data. The author helped draft the output.

Interdisciplinary
-
Cross-referral requested
-
Research group
None
Citation count
132
Proposed double-weighted
No
Double-weighted statement
-
Reserve for a double-weighted output
No
Non-English
No
English abstract
-